Dr. Melissa H. Wong's lab focuses on understanding how certain cancer cells spread from primary tumors to other parts of the body, which is a major challenge in treating cancer. They study a specific type of cancer cell, known as circulating hybrid cells, that may play a critical role in metastasis. Through advanced analyses and techniques, the lab aims to uncover the biological mechanisms that allow these cells to disseminate, which could lead to improved treatments for patients with colorectal cancer and other metastatic diseases.

Dr. Laura Delong Wood's lab at Johns Hopkins University focuses on understanding how precancerous lesions in the pancreas evolve into cancer. By analyzing the genetics of these lesions and using advanced computational techniques, the lab aims to uncover the processes that lead to pancreatic cancer. This research hopes to pave the way for better early detection and treatment of pancreatic cancer by revealing crucial insights into its development.

Dr. Carl Wu's lab at Johns Hopkins University focuses on understanding how genes are expressed in living cells by studying the processes that regulate chromatin, the structure that organizes DNA. They use advanced techniques to visualize how proteins interact with DNA and regulate gene activity, particularly under stress conditions like heat. The lab aims to uncover the precise timing and mechanics of these processes to enhance our understanding of gene regulation and its implications for various biological functions.

Dr. Joshua D. Wythe's lab at the University of Virginia focuses on understanding brain arteriovenous malformations (bAVMs), which are dangerous blood vessel abnormalities that can lead to stroke, especially in children and young adults. The lab investigates the cellular and molecular mechanisms behind these conditions, particularly looking at genetic mutations and endothelial cell behavior. By using animal models, the team aims to find safer, drug-based treatments for these serious vascular issues.

Dr. Jinrui Xu's research lab focuses on understanding essential genes—those that are crucial for cell survival and function. The lab employs advanced computational methods, particularly a novel framework that uses graph neural networks, to predict gene essentiality and identify important protein structures. This research aims to bridge the gap between computational models and biological insights, ultimately contributing to advancements in drug discovery and precision medicine.

Dr. Xiaowei Xu's lab focuses on developing innovative therapies using advanced immunological approaches to combat melanoma, a serious skin cancer. The lab utilizes humanized mouse models to study immune responses and explore the potential of engineered immune cells and extracellular vesicles in targeted cancer therapies. Their research aims to make significant advancements in the effectiveness of existing cancer treatments while minimizing side effects.

Dr. Jianliang Xu's lab focuses on developing innovative treatments for HIV using nanobodies, which are smaller and more versatile than traditional antibodies. The lab aims to create nanobodies that can target multiple sites on the HIV virus, potentially improving treatment effectiveness and simplifying administration. Their work could lead to breakthrough therapies that enhance the fight against AIDS and offer new hope for patients worldwide.

Dr. Hong Xu's lab at the University of Pennsylvania focuses on understanding tauopathies, which are neurodegenerative diseases associated with the abnormal accumulation of tau proteins in the brain. The lab investigates how a protein called ASAP1 influences the spreading of tau pathology, potentially leading to better treatments for conditions like Alzheimer's disease. By studying how tau spreads and its interaction with cellular pathways, the lab aims to identify new therapeutic targets for these devastating diseases.

Dr. Xiangmin Xu's lab focuses on understanding how aging and Alzheimer's disease (AD) affect brain circuits and cellular functions. They use advanced mouse models and cutting-edge techniques to investigate the molecular mechanisms that lead to cognitive deficits in AD. Through their work, the lab aims to create better diagnostic tools and treatment strategies for this debilitating condition.

Dr. Ling Yang's lab at the University of Iowa focuses on understanding how lysosomal dysfunction affects heart health, specifically in the context of heart failure with preserved ejection fraction (HFpEF). The lab uses innovative methods to study the role of lysosomes in controlling metabolic processes and inflammation in heart cells, aiming to uncover new therapeutic strategies for managing heart disease. Overall, the research will improve our understanding of the molecular mechanisms underlying cardiovascular health and disease.

Dr. Xiaolu Yang's lab at the University of Pennsylvania focuses on understanding how specific proteins affect the development and progression of neurodegenerative diseases like ALS and FTD. They investigate the roles of unique proteins involved in maintaining the stability and function of other proteins in the cell, particularly regarding protein aggregation, which is a key feature in many diseases. Their research aims to explore potential therapeutic strategies to combat these conditions by enhancing our understanding of protein quality control mechanisms in cells.

Dr. Xiaoyong Yang's lab focuses on the role of a specific brain region, the ventromedial hypothalamus (VMH), in regulating body weight and metabolism. By studying the molecular mechanisms of O-GlcNAc transferase (OGT) in the VMH, the lab aims to understand how the brain senses nutrients and hormones to control energy balance and adipose tissue function. This research could lead to new therapies for obesity and related health issues.

Dr. Hongdian Yang's lab at the University of California Riverside studies how the brain allows us to adapt our behaviors based on our goals. By examining specific brain regions, the lab aims to uncover how different parts of the brain communicate to manage flexible decision-making in tasks that require tactile discrimination. This research is essential for understanding cognitive functions and may provide insights into neurological disorders.

Dr. Michael Yassa's lab at UC Irvine focuses on unraveling the complexities of memory and its impact on mental health and neurodegenerative diseases. Research in the lab investigates conditions like anhedonia—a loss of pleasure—by exploring its relationship with memory processing and neural circuitry. The lab also examines how cerebrovascular health affects Alzheimer’s disease progression, especially in minority populations, aiming to develop predictive biomarkers that can guide interventions and improve clinical outcomes.

Dr. Deborah Yelon's lab at UC San Diego focuses on understanding how the heart maintains its distinct chamber identities, particularly between the atria and ventricles, using zebrafish as a model organism. The lab explores the genetic pathways that reinforce these identities and examines how they can change under different conditions. This research aims to shed light on the mechanisms behind heart development and potential strategies for addressing congenital heart diseases.

Omer Yilmaz's lab studies the role of lysosomes in intestinal stem cells and cancer, particularly how fasting influences these processes. By investigating how lysosomes help maintain stem cells and contribute to the development of tumors, the lab hopes to uncover new therapies for improving health through better understanding of cellular and organismal physiology. Their work combines genetics, biochemistry, and cutting-edge techniques to explore the underlying mechanisms involved in stem cell function and tumor progression.

Dr. Bradley K. Yoder's research lab focuses on understanding the role of cilia and their associated proteins in kidney health and disease. Their work investigates how mutations in certain genes cause kidney cysts and how these cysts are influenced by injury and cellular repair processes. By using mouse models, the lab aims to uncover the mechanisms behind cyst formation and identify potential therapeutic strategies to better manage polycystic kidney disease (PKD).

Dr. Jessica Elaine Young's research lab focuses on understanding the mechanisms behind Alzheimer's Disease (AD), particularly the roles of genetics and cell type-specific functions in disease progression. Her lab investigates endo-lysosomal dysfunction in human neural cells and how sex-linked genetic factors influence the onset and progression of AD. By utilizing human-induced pluripotent stem cells (hiPSCs) and patient-derived tissues, the lab aims to identify potential therapeutic targets for AD and better understand the differential effects of genetics on male and female patients.

Dr. Lixia Yue's lab at the University of Connecticut focuses on understanding the mechanisms behind cardiac fibrosis, a condition that contributes to various heart diseases. By investigating a specific ion channel called TRPM7 in cardiac fibroblasts, the lab aims to explore therapeutic targets for improving treatment options for heart failure. The research combines molecular biology with advanced animal models to uncover how signaling pathways influence heart health.

Dr. Rafael Yuste's lab at Columbia University investigates the complex workings of the visual cortex, focusing on the role of neuronal ensembles and dendrites in processing visual information. His team uses advanced optical techniques to explore how these ensembles affect visual perception and how dendrites, often overlooked in neuroscience, contribute to neuronal decision-making. Ultimately, this research aims to better understand brain function and develop novel therapies for visual impairments.